AB Science Corporate Presentation Post navigationPreviousPrevious post:AB8939 receives Orphan Drug Designation for Acute Myeloid Leukemia from FDANextNext post:Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authoritiesRelated PostsGovernanceMay 9, 2018General Meeting preparatory documentsMay 6, 2018Other informationMay 5, 2018Frequently Asked QuestionsMay 1, 2018